508 related articles for article (PubMed ID: 9745419)
1. Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.
Bhasin S; Storer TW; Asbel-Sethi N; Kilbourne A; Hays R; Sinha-Hikim I; Shen R; Arver S; Beall G
J Clin Endocrinol Metab; 1998 Sep; 83(9):3155-62. PubMed ID: 9745419
[TBL] [Abstract][Full Text] [Related]
2. Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.
Bhasin S; Parker RA; Sattler F; Haubrich R; Alston B; Umbleja T; Shikuma CM;
J Clin Endocrinol Metab; 2007 Mar; 92(3):1049-57. PubMed ID: 17164307
[TBL] [Abstract][Full Text] [Related]
3. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
[TBL] [Abstract][Full Text] [Related]
4. Serum dihydrotestosterone and testosterone concentrations in human immunodeficiency virus-infected men with and without weight loss.
Arver S; Sinha-Hikim I; Beall G; Guerrero M; Shen R; Bhasin S
J Androl; 1999; 20(5):611-8. PubMed ID: 10520573
[TBL] [Abstract][Full Text] [Related]
5. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting.
Grinspoon S; Corcoran C; Miller K; Biller BM; Askari H; Wang E; Hubbard J; Anderson EJ; Basgoz N; Heller HM; Klibanski A
J Clin Endocrinol Metab; 1997 May; 82(5):1332-7. PubMed ID: 9141512
[TBL] [Abstract][Full Text] [Related]
6. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
[TBL] [Abstract][Full Text] [Related]
7. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.
Miller K; Corcoran C; Armstrong C; Caramelli K; Anderson E; Cotton D; Basgoz N; Hirschhorn L; Tuomala R; Schoenfeld D; Daugherty C; Mazer N; Grinspoon S
J Clin Endocrinol Metab; 1998 Aug; 83(8):2717-25. PubMed ID: 9709937
[TBL] [Abstract][Full Text] [Related]
8. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.
Wang C; Swerdloff RS; Iranmanesh A; Dobs A; Snyder PJ; Cunningham G; Matsumoto AM; Weber T; Berman N;
J Clin Endocrinol Metab; 2000 Aug; 85(8):2839-53. PubMed ID: 10946892
[TBL] [Abstract][Full Text] [Related]
9. The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone.
Herbst KL; Anawalt BD; Amory JK; Matsumoto AM; Bremner WJ
J Clin Endocrinol Metab; 2003 Mar; 88(3):1167-73. PubMed ID: 12629101
[TBL] [Abstract][Full Text] [Related]
10. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.
Allan CA; Strauss BJ; Burger HG; Forbes EA; McLachlan RI
J Clin Endocrinol Metab; 2008 Jan; 93(1):139-46. PubMed ID: 17940111
[TBL] [Abstract][Full Text] [Related]
11. Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss.
Knapp PE; Storer TW; Herbst KL; Singh AB; Dzekov C; Dzekov J; LaValley M; Zhang A; Ulloor J; Bhasin S
Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1135-43. PubMed ID: 18430965
[TBL] [Abstract][Full Text] [Related]
12. Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels.
Bhasin S; Storer TW; Javanbakht M; Berman N; Yarasheski KE; Phillips J; Dike M; Sinha-Hikim I; Shen R; Hays RD; Beall G
JAMA; 2000 Feb; 283(6):763-70. PubMed ID: 10683055
[TBL] [Abstract][Full Text] [Related]
13. Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss.
Choi HH; Gray PB; Storer TW; Calof OM; Woodhouse L; Singh AB; Padero C; Mac RP; Sinha-Hikim I; Shen R; Dzekov J; Dzekov C; Kushnir MM; Rockwood AL; Meikle AW; Lee ML; Hays RD; Bhasin S
J Clin Endocrinol Metab; 2005 Mar; 90(3):1531-41. PubMed ID: 15613414
[TBL] [Abstract][Full Text] [Related]
14. Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy.
Howell SJ; Radford JA; Adams JE; Smets EM; Warburton R; Shalet SM
Clin Endocrinol (Oxf); 2001 Sep; 55(3):315-24. PubMed ID: 11589674
[TBL] [Abstract][Full Text] [Related]
15. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
[TBL] [Abstract][Full Text] [Related]
16. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A
J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
[TBL] [Abstract][Full Text] [Related]
17. Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.
Grinspoon S; Corcoran C; Askari H; Schoenfeld D; Wolf L; Burrows B; Walsh M; Hayden D; Parlman K; Anderson E; Basgoz N; Klibanski A
Ann Intern Med; 1998 Jul; 129(1):18-26. PubMed ID: 9652995
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of a novel testosterone matrix transdermal system in healthy, premenopausal women and women infected with the human immunodeficiency virus.
Javanbakht M; Singh AB; Mazer NA; Beall G; Sinha-Hikim I; Shen R; Bhasin S
J Clin Endocrinol Metab; 2000 Jul; 85(7):2395-401. PubMed ID: 10902784
[TBL] [Abstract][Full Text] [Related]
19. Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception.
Young NR; Baker HW; Liu G; Seeman E
J Clin Endocrinol Metab; 1993 Oct; 77(4):1028-32. PubMed ID: 8408450
[TBL] [Abstract][Full Text] [Related]
20. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.
Page ST; Amory JK; Bowman FD; Anawalt BD; Matsumoto AM; Bremner WJ; Tenover JL
J Clin Endocrinol Metab; 2005 Mar; 90(3):1502-10. PubMed ID: 15572415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]